Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)

v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Parent
Common Stock
Additional paid in capital
Retained earnings
Accumulated other comprehensive (loss)/income
Non- controlling interest
Beginning balance (in shares) at Mar. 31, 2021     58,443,212,000        
Equity, beginning of period at Mar. 31, 2021 $ 307,671 $ 309,312 $ 58 $ 135,260 $ 214,427 $ (40,433) $ (1,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation 11,281 11,281 $ 1 11,280      
Stock based compensation (in shares)     1,031,500,000        
Sale of Freedom Ukraine shares 416 (796)   (796)     1,212
Contribution of shareholder 1,966 1,966   1,966      
Exercise of options (in shares)     60,000,000        
Exercise of options 119 119   119      
Other comprehensive loss (183) (183)       (183)  
Translation difference (4,447) (4,447)       (4,447)  
Net income/(loss) 316,184 316,599     316,599   (415)
Ending balance (in shares) at Dec. 31, 2021     59,534,712,000        
Equity, end of period at Dec. 31, 2021 633,007 633,851 $ 59 147,829 531,026 (45,063) (844)
Beginning balance (in shares) at Sep. 30, 2021     59,534,712,000        
Equity, beginning of period at Sep. 30, 2021 583,132 583,633 $ 59 143,268 476,610 (36,304) (501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation 4,561 4,561   4,561      
Other comprehensive loss (109) (109)       (109)  
Translation difference (8,650) (8,650)       (8,650)  
Net income/(loss) 54,073 54,416     54,416   (343)
Ending balance (in shares) at Dec. 31, 2021     59,534,712,000        
Equity, end of period at Dec. 31, 2021 $ 633,007 633,851 $ 59 147,829 531,026 (45,063) (844)
Beginning balance (in shares) at Mar. 31, 2022 59,542,212   59,542,212        
Equity, beginning of period at Mar. 31, 2022 $ 546,608 [1] 553,603 $ 59 174,745 441,924 (63,125) (6,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation 10,746 10,746   10,746      
Contribution of shareholder 677 677   677      
Other comprehensive loss 2,506 2,506       2,506  
Acquisition of insurance companies (26,588) (26,588)   (26,588)      
Translation difference (301) (301)       (301)  
Net income/(loss) $ 148,683 150,191     150,191   (1,508)
Ending balance (in shares) at Dec. 31, 2022 59,542,212   59,542,212        
Equity, end of period at Dec. 31, 2022 $ 682,331 690,834 $ 59 159,580 592,115 (60,920) (8,503)
Beginning balance (in shares) at Sep. 30, 2022     59,542,212        
Equity, beginning of period at Sep. 30, 2022 621,331 629,370 $ 59 155,635 529,251 (55,575) (8,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation 3,945 3,945   3,945      
Other comprehensive loss 266 266       266  
Translation difference (5,611) (5,611)       (5,611)  
Net income/(loss) $ 62,400 62,864     62,864   (464)
Ending balance (in shares) at Dec. 31, 2022 59,542,212   59,542,212        
Equity, end of period at Dec. 31, 2022 $ 682,331 $ 690,834 $ 59 $ 159,580 $ 592,115 $ (60,920) $ (8,503)
[1] * Please see Note 3